What is the appropriate pediatric dosage of Augmentin (amoxicillin/clavulanate) for outpatient treatment of paronychia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric Augmentin Dosing for Outpatient Paronychia

For pediatric patients ≥3 months with paronychia requiring outpatient antibiotic therapy, prescribe amoxicillin-clavulanate (Augmentin) at 45 mg/kg/day divided twice daily (based on the amoxicillin component), administered for 7-10 days with meals. 1

Dosing Rationale and Formulation Selection

The standard-dose formulation (not the high-dose ES-600) is appropriate for paronychia, as this is a soft tissue infection without the same resistance concerns seen in recurrent otitis media. The twice-daily regimen improves compliance and reduces gastrointestinal side effects compared to three-times-daily dosing 2.

Specific Weight-Based Dosing

For the standard formulation providing approximately 45 mg/kg/day:

  • Use the 400 mg/5 mL suspension
  • Dose: approximately 22.5 mg/kg per dose, twice daily
  • Example: A 20 kg child would receive approximately 10 mL (400 mg) twice daily

Critical formulation warning: Do not substitute different Augmentin suspensions interchangeably - they contain different amounts of clavulanic acid. The 200 mg/5 mL, 400 mg/5 mL, and ES-600 formulations are NOT equivalent 1.

Clinical Context for Paronychia

Paronychia is classified as a skin and soft tissue infection requiring coverage of both aerobic and anaerobic bacteria. The 2014 IDSA guidelines specifically recommend amoxicillin-clavulanate for bite wounds and infections requiring mixed aerobic-anaerobic coverage 3. While paronychia isn't explicitly mentioned, it falls within this category of polymicrobial soft tissue infections.

Recent microbiological data shows Staphylococcus aureus is the predominant pathogen (approximately 30% of cases), with amoxicillin-clavulanate demonstrating only 4.7% resistance rates 4. This supports its use as empiric first-line therapy.

Administration Guidelines

  • Timing: Administer at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 1
  • Duration: 7-10 days is standard for uncomplicated paronychia
  • Storage: Reconstituted suspension remains stable for 10 days under refrigeration 1
  • Preparation: Shake well before each use

Key Caveats and Pitfalls

Age restriction: This dosing applies only to children ≥3 months old. Neonates and infants <3 months require different considerations 1.

Hepatic impairment: Dose with caution and monitor hepatic function in patients with liver disease 1.

When NOT to use antibiotics: For simple, uncomplicated paronychia that can be adequately drained, postoperative antibiotics may not influence recurrence rates and should be avoided to support antimicrobial stewardship 4.

Resistance considerations: If the patient has risk factors for MRSA (recent hospitalization, recurrent skin infections, prior MRSA), amoxicillin-clavulanate will not provide adequate coverage and alternative agents should be considered 3.

Practical Prescribing

The twice-daily regimen shows equivalent efficacy to three-times-daily dosing with trends toward better compliance (82.8% vs 73.3%) and lower diarrhea rates (7.2% vs 10.7%) 2. This makes it the preferred outpatient regimen for pediatric patients.

For patients requiring higher doses due to treatment failure or resistant organisms, the ES-600 formulation provides 90 mg/kg/day divided twice daily, but this is typically reserved for recurrent/persistent infections rather than initial paronychia treatment 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.